Nexien BioPharma
Financial ratios & Valuation

Historical Multiples (2015 – 2024)

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 TTM Median
Valuation Ratios
Price/Earnings ratio
-562.59-216.41-111.83-131.34-0.91-0.98-2.65-5.77-6.15-4.87-0.00-0.91
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
-557.13-64.9751.35142.4017.27-415.04-361.15-30.74-8.84-3.22-0.01-0.01
Price/Cash Flow ratio
-583.18-277.76-223.31-192.54-7.13-17.90-54.82-48.12-27.25-18.10-0.05-7.13
Price/Free Cash Flow ratio
-583.18-277.76-148.69-185.13-6.82-17.90-54.82-48.12-27.25-18.10-0.05-6.82
Price/Earnings Growth ratio
N/A-1.33-1.18-0.72-0.000.010.080.080.130.12-0.00-0.00
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
N/A108.70%296.04%99.99%-17.10%-0.00%-0.86%0.09%0.07%100%N/A-17.10%
Return on Assets
N/AN/A-33.43%-100.85%-1621.25%-11724.96%-7345.51%-503.02%-839.15%-5716.30%-614.41%-1621.25%
Return On Equity
99.02%30.02%-45.91%-108.42%-1894.08%41974.07%13619.72%532.59%143.60%66.19%347.86%-1894.08%
Return on Capital Employed
99.02%23.38%-45.91%-108.42%-1340.65%41423.15%13384.87%479.56%112.14%43.09%116.42%-1340.65%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.27N/A
Quick Ratio
N/AN/A2.49168.95K6.940.780.640.510.140.010.240.78
Cash ratio
N/AN/A1.159.233.270.370.450.480.110.010.240.37
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/A0.520.501.786.2974.643.623.62
Debt Equity Ratio
N/AN/AN/AN/AN/A-1.88-0.93-1.88-1.07-0.86-1.38-1.38
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Total Debt to Capitalization
N/AN/AN/AN/AN/A2.12-15.512.1213.93-6.37N/A2.12
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-4.38N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/A-12.29-7.01-0.33-0.30-0.20N/AN/A
Company Equity Multiplier
N/AN/A1.371.071.16-3.57-1.85-1.05-0.17-0.01-0.38-0.38
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
111.501.031.041111111
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/A-12.29-7.01-0.33-0.30-0.20N/AN/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/A-12.29-7.01-0.33-0.30-0.20N/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A